These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin. Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065 [No Abstract] [Full Text] [Related]
24. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs]. Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794 [No Abstract] [Full Text] [Related]
25. [Synthesis and properties of the N-acyl derivatives of carminomycin and rubomycin]. Olsuf'eva EN; Povarov LS Antibiotiki; 1980 May; 25(5):333-8. PubMed ID: 7387126 [TBL] [Abstract][Full Text] [Related]
26. Letter: Total synthesis of (+/-)-daunomycinone and (+/-)-carminomycinone. Kende AS; Tsay YG; Mills JE J Am Chem Soc; 1976 Mar; 98(7):1967-9. PubMed ID: 1254856 [No Abstract] [Full Text] [Related]
28. [Semisynthetic derivatives of daunorubicin and carminomycin: inhibition of DNA synthesis after intravenous administration to mice]. Reznikova MI; Dudnik IuV Antibiot Khimioter; 1988 Sep; 33(9):653-7. PubMed ID: 3218988 [TBL] [Abstract][Full Text] [Related]
29. [Current status of clinical results of new antitumor drugs]. Ogawa M Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502 [TBL] [Abstract][Full Text] [Related]
30. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. Young CW; Raymond V Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251 [No Abstract] [Full Text] [Related]
33. [Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives]. Povarov LS Antibiotiki; 1977 Jul; 22(7):653-67. PubMed ID: 883809 [No Abstract] [Full Text] [Related]
34. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin]. Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147 [TBL] [Abstract][Full Text] [Related]
35. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone. Dornberger K; Hübener R; Ihn W; Thrum H; Radics L J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504 [TBL] [Abstract][Full Text] [Related]
37. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities. Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366 [TBL] [Abstract][Full Text] [Related]
38. [Changes in the spatial organization of DNA molecules induced by anthracycline antibiotics]. Salianov VI; Evdokimov IuM; Berg G Antibiotiki; 1982 Dec; 27(12):38-42. PubMed ID: 6962685 [TBL] [Abstract][Full Text] [Related]